Diabetes Metab J.  2019 Dec;43(6):785-793. 10.4093/dmj.2018.0218.

Early Assessment of the Risk for Gestational Diabetes Mellitus: Can Fasting Parameters of Glucose Metabolism Contribute to Risk Prediction?

• Falcone V
• Kotzaeridi G
• Breil MH
• Rosicky I
• Stopp T
• Yerlikaya-Schatten G
• Feichtinger M
• Eppel W
• Husslein P
• Tura A
• Göbl CS

• KMID: 2466500
• DOI: http://doi.org/10.4093/dmj.2018.0218

Abstract

BACKGROUND
An early identification of the risk groups might be beneficial in reducing morbidities in patients with gestational diabetes mellitus (GDM). Therefore, this study aimed to assess the biochemical predictors of glycemic conditions, in addition to fasting indices of glucose disposal, to predict the development of GDM in later stage and the need of glucose-lowering medication.
METHODS
A total of 574 pregnant females (103 with GDM and 471 with normal glucose tolerance [NGT]) were included. A metabolic characterization was performed before 15+6 weeks of gestation by assessing fasting plasma glucose (FPG), fasting insulin (FI), fasting C-peptide (FCP), and glycosylated hemoglobin (HbA1c). Thereafter, the patients were followed-up until the delivery.
RESULTS
Females with NGT had lower levels of FPG, FI, FCP, or HbA1c at the early stage of pregnancy, and therefore, showed an improved insulin action as compared to that in females who developed GDM. Higher fasting levels of FPG and FCP were associated with a higher risk of developing GDM. Moreover, the predictive accuracy of this metabolic profiling was also good to distinguish the patients who required glucose-lowering medications. Indices of glucose disposal based on C-peptide improved the predictive accuracy compared to that based on insulin. A modified quantitative insulin sensitivity check index (QUICKIc) showed the best differentiation in terms of predicting GDM (area under the receiver operating characteristics curve [ROC-AUC], 72.1%) or need for pharmacotherapy (ROC-AUC, 83.7%).
CONCLUSION
Fasting measurements of glucose and C-peptide as well as the surrogate indices of glycemic condition could be used for stratifying pregnant females with higher risk of GDM at the beginning of pregnancy.

Keyword

Diabetes, gestational; Glucose metabolism disorders; Insulin resistance; Insulin secretion; Metabolic diseases

MeSH Terms

Blood Glucose
C-Peptide
Diabetes, Gestational*
Drug Therapy
Fasting*
Female
Glucose Metabolism Disorders
Glucose*
Hemoglobin A, Glycosylated
Humans
Insulin
Insulin Resistance
Metabolic Diseases
Metabolism*
Pregnancy
ROC Curve
C-Peptide
Glucose
Insulin

Figure

• 

  Fig. 1 Receiver operating characteristic curves for prediction of gestational diabetes mellitus (GDM) and initiation of pharmacotherapy in GDM (GDM-PT) using (A, D) fasting plasma glucose (FPG), (B, E) fasting C-peptide (FCP), and (C, F) quantitative insulin sensitivity check index from C-peptide (QUICKIc). AUC, area under curve; CI, confidence interval.

Reference

1. Williams D. Pregnancy: a stress test for life. Curr Opin Obstet Gynecol. 2003; 15:465–471. PMID: 14624211.

2. Agha-Jaffar R, Oliver N, Johnston D, Robinson S. Gestational diabetes mellitus: does an effective prevention strategy exist? Nat Rev Endocrinol. 2016; 12:533–546. PMID: 27339886.

3. HAPO Study Cooperative Research Group. Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008; 358:1991–2002. PMID: 18463375.

4. Gobl CS, Bozkurt L, Prikoszovich T, Winzer C, Pacini G, Kautzky-Willer A. Early possible risk factors for overt diabetes after gestational diabetes mellitus. Obstet Gynecol. 2011; 118:71–78. PMID: 21691165.

5. Tura A, Grassi A, Winhofer Y, Guolo A, Pacini G, Mari A, Kautzky-Willer A. Progression to type 2 diabetes in women with former gestational diabetes: time trajectories of metabolic parameters. PLoS One. 2012; 7:e50419. PMID: 23185618.

6. International Association of Diabetes and Pregnancy Study Groups Consensus Panel. Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, Dyer AR, Leiva Ad, Hod M, Kitzmiler JL, Lowe LP, McIntyre HD, Oats JJ, Omori Y, Schmidt MI. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010; 33:676–682. PMID: 20190296.

7. American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018. Diabetes Care. 2018; 41(Suppl 1):S13–S27. PMID: 29222373.

8. Riskin-Mashiah S, Younes G, Damti A, Auslender R. First-trimester fasting hyperglycemia and adverse pregnancy outcomes. Diabetes Care. 2009; 32:1639–1643. PMID: 19549728.

9. Vesco KK, Karanja N, King JC, Gillman MW, Leo MC, Perrin N, McEvoy CT, Eckhardt CL, Smith KS, Stevens VJ. Efficacy of a group-based dietary intervention for limiting gestational weight gain among obese women: a randomized trial. Obesity (Silver Spring). 2014; 22:1989–1996. PMID: 25164259.

10. Powe CE. Early pregnancy biochemical predictors of gestational diabetes mellitus. Curr Diab Rep. 2017; 17:12. PMID: 28229385.

11. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979; 237:E214–E223. PMID: 382871.

12. Pacini G, Tonolo G, Sambataro M, Maioli M, Ciccarese M, Brocco E, Avogaro A, Nosadini R. Insulin sensitivity and glucose effectiveness: minimal model analysis of regular and insulin-modified FSIGT. Am J Physiol. 1998; 274:E592–E599. PMID: 9575818.

13. Tura A, Chemello G, Szendroedi J, Gobl C, Faerch K, Vrbikova J, Pacini G, Ferrannini E, Roden M. Prediction of clamp-derived insulin sensitivity from the oral glucose insulin sensitivity index. Diabetologia. 2018; 61:1135–1141. PMID: 29484470.

14. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004; 27:1487–1495. PMID: 15161807.

15. American Diabetes Association. 13. Management of diabetes in pregnancy: standards of medical care in diabetes-2018. Diabetes Care. 2018; 41(Suppl 1):S137–S143. PMID: 29222384.

16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28:412–419. PMID: 3899825.

17. Tura A, Kautzky-Willer A, Pacini G. Insulinogenic indices from insulin and C-peptide: comparison of beta-cell function from OGTT and IVGTT. Diabetes Res Clin Pract. 2006; 72:298–301. PMID: 16325298.

18. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000; 85:2402–2410. PMID: 10902785.

19. The R Foundation: The R Project for Statistical Computing. cited 2019 Jan 21. Available from: https://www.r-project.org/.

20. World Health Organization. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. Geneva: World Health Organization;2013. cited 2019 Jan 21. Available from: http://www.ncbi.nlm.nih.gov/books/NBK169024/.

21. Hod M, Kapur A, Sacks DA, Hadar E, Agarwal M, Di Renzo GC, Cabero Roura L, McIntyre HD, Morris JL, Divakar H. The International Federation of Gynecology and Obstetrics (FIGO) initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet. 2015; 131 Suppl 3:S173–S211.

22. McIntyre HD, Sacks DA, Barbour LA, Feig DS, Catalano PM, Damm P, McElduff A. Issues with the diagnosis and classification of hyperglycemia in early pregnancy. Diabetes Care. 2016; 39:53–54. PMID: 26519336.

23. Corrado F, D’Anna R, Cannata ML, Interdonato ML, Pintaudi B, Di Benedetto A. Correspondence between first-trimester fasting glycaemia, and oral glucose tolerance test in gestational diabetes diagnosis. Diabetes Metab. 2012; 38:458–461. PMID: 22595470.

24. Zhu WW, Yang HX, Wei YM, Yan J, Wang ZL, Li XL, Wu HR, Li N, Zhang MH, Liu XH, Zhang H, Wang YH, Niu JM, Gan YJ, Zhong LR, Wang YF, Kapur A. Evaluation of the value of fasting plasma glucose in the first prenatal visit to diagnose gestational diabetes mellitus in china. Diabetes Care. 2013; 36:586–590. PMID: 23193214.

25. Hughes RC, Rowan J, Florkowski CM. Is there a role for HbA1c in pregnancy? Curr Diab Rep. 2016; 16:5. PMID: 26739347.

26. Gobl CS, Bozkurt L, Yarragudi R, Tura A, Pacini G, Kautzky-Willer A. Is early postpartum HbA1c an appropriate risk predictor after pregnancy with gestational diabetes mellitus? Acta Diabetol. 2014; 51:715–722. PMID: 24626995.

27. Fong A, Serra AE, Gabby L, Wing DA, Berkowitz KM. Use of hemoglobin A1c as an early predictor of gestational diabetes mellitus. Am J Obstet Gynecol. 2014; 211:641. PMID: 24912095.

28. Amylidi S, Mosimann B, Stettler C, Fiedler GM, Surbek D, Raio L. First-trimester glycosylated hemoglobin in women at high risk for gestational diabetes. Acta Obstet Gynecol Scand. 2016; 95:93–97. PMID: 26400192.

29. Agarwal MM, Dhatt GS, Punnose J, Koster G. Gestational diabetes: a reappraisal of HBA1c as a screening test. Acta Obstet Gynecol Scand. 2005; 84:1159–1163. PMID: 16305701.

30. Jones AG, Hattersley AT. The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabet Med. 2013; 30:803–817. PMID: 23413806.

31. Bozkurt L, Gobl CS, Pfligl L, Leitner K, Bancher-Todesca D, Luger A, Baumgartner-Parzer S, Pacini G, Kautzky-Willer A. Pathophysiological characteristics and effects of obesity in women with early and late manifestation of gestational diabetes diagnosed by the International Association of Diabetes and Pregnancy Study Groups criteria. J Clin Endocrinol Metab. 2015; 100:1113–1120. PMID: 25574889.

32. Lapolla A, Dalfra MG, Mello G, Parretti E, Cioni R, Marzari C, Masin M, Ognibene A, Messeri G, Fedele D, Mari A, Pacini G. Early detection of insulin sensitivity and beta-cell function with simple tests indicates future derangements in late pregnancy. J Clin Endocrinol Metab. 2008; 93:876–880. PMID: 18089696.

33. Abdul-Ghani MA, Tripathy D, DeFronzo RA. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care. 2006; 29:1130–1139. PMID: 16644654.

34. Gobl CS, Bozkurt L, Mittlbock M, Leutner M, Yarragudi R, Tura A, Pacini G, Kautzky-Willer A. To explain the variation of OGTT dynamics by biological mechanisms: a novel approach based on principal components analysis in women with history of GDM. Am J Physiol Regul Integr Comp Physiol. 2015; 309:R13–R21. PMID: 25924879.